Inhibrx Biosciences, Inc.INBXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
34.10%
↑ 232% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
-25.90%
Historical baseline
PeriodValue
202534.10%
20240.45%
2023-70.62%
2022-42.86%
2021-64.57%
2020-45.57%
2019-38.20%
2018-22.04%
2017-9.65%
20160.00%